Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021;182(1):76-82.
doi: 10.1159/000510953. Epub 2020 Sep 22.

Does Asthma Increase the Mortality of Patients with COVID-19?: A Systematic Review and Meta-Analysis

Yuanyuan Wang  1 , Jingjing Chen  1 , Wei Chen  2 , Ling Liu  2 , Mei Dong  2 , Juan Ji  2 , Die Hu  3 , Nianzhi Zhang  4
Affiliations
Meta-Analysis

Does Asthma Increase the Mortality of Patients with COVID-19?: A Systematic Review and Meta-Analysis

Yuanyuan Wang et al. Int Arch Allergy Immunol. 2021.

Abstract

The purpose of this systematic review and meta-analysis was to explore the literature and collate data comparing the mortality of coronavirus disease 2019 (COVID-19) patients with and without asthma. The databases PubMed, Scopus, Embase, Google Scholar, and medRxiv.org were searched for studies comparing the clinical outcomes of asthmatic patients with those of nonasthmatic patients diagnosed with COVID-19. Mortality data were summarized using the Mantel-Haenszel OR with 95% CI in a random-effects model. Five retrospective studies met the inclusion criteria. A meta-analysis of data from 744 asthmatic patients and 8,151 nonasthmatic patients indicated that the presence of asthma had no significant effect on mortality (OR = 0.96; 95% CI 0.70-1.30; I2 = 0%; p = 0.79). Results were stable in a sensitivity analysis. A descriptive analysis of other clinical outcomes indicated no difference in the duration of hospitalization and the risk of intensive care unit (ICU) transfer between asthmatic and nonasthmatic patients. To conclude, preliminary data indicates that asthma as a comorbidity may not increase the mortality of COVID-19. Data on the influence of asthma on the risk of hospitalization, the duration of hospitalization, the requirement of ICU admission, and disease severity is still too limited to draw any strong conclusions. Further studies with a larger sample size are required to establish strong evidence.

Keywords: Asthma; COVID-19; Coronavirus; Death; Respiratory disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

Figures

Fig. 1
Fig. 1
Study flow chart
Fig. 2
Fig. 2
Forest plot of mortality with COVID-19 with and without asthma [13, 14, 15, 17]. IV, instrumental variable.
See this image and copyright information in PMC

References

    1. World Health Organization Coronavirus situation report. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
    1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb;323((11)):1061. - PMC - PubMed
    1. Jiang Y, He S, Zhang C, Wang X, Chen X, Jin Y, et al. Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China. Ann Transl Med. 2020 Apr;8((8)):547–547. - PMC - PubMed
    1. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020 Mar;323((16)):1612–4. - PMC - PubMed
    1. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. and the Northwell COVID-19 Research Consortium Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 Apr;323((20)):2052–9. - PMC - PubMed